Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibroblasts, and endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 4, 2005, Pages 692-697

  Galli, Daniela ^a   Innocenzi, Anna ^a   Staszewsky, Lidia ^b   Zanetta, Lucia ^c   Sampaolesi, Maurilio ^a   Bai, Antonio ^b   Martinoli, Elena ^b   Carlo, Eleonora ^b   Balconi, Giovanna ^b   Fiordaliso, Fabio ^b   Chimenti, Stefano ^b   Cusella, Gabriella ^a,d   Dejana, Elisabetta ^b,c,e   Cossu, Giulio ^a,f,g   Latini, Roberto ^b  

^a Stem Cell Research Institute   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g Institute of Cell Biology and Tissue Engineering   (Italy)

Author keywords

Angiogenesis; Mesoangioblasts; Myocardial infarction; Myogenesis; Stem cells

Indexed keywords

FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; SCATTER FACTOR; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; IN VITRO STUDY; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; VESSEL;

ANIMALS; APOPTOSIS; BLOOD VESSELS; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; MESODERM; MICE; MICE, INBRED C57BL; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20144387678     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000156402.52029.ce     Document Type: Article

References (25)

1. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res. 2002;91:1092-1102.
2. Caplice NM, and Gersch BJ. Stem cells to repair the heart. A clinical perspective. Circ Res. 2003;92:6-8.
3. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Nickel J, McKay R, Nadal-Ginard B. Bodine DM et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
4. Jackson K.A Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402.
5. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KBS, Virag JI, Bartelmez SH, Poppa V, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-668.
6. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668-673.
7. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
8. Menasché P. Skeletal muscle satellite cell transplantation. Cardiovasc Res. 2003;58:351-357.
9. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol. 1999;31:513-522.
10. Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasche P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119:1169-1175.
11. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002;92:288-296.
12. Aicher A. Brenner W, Zuhayra M, Badorff C. Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139.
13. Itescu S, Schuster MD, Kocher AA. New directions in strategies using cell therapy for heart disease. J Mol Med. 2003;81:288-296.
14. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
15. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A, Caprioli A, Sirabella D, Baiocchi M, De Maria R et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development. 2002;129:2773-2783.
16. Tagliafico E, Brunelli S, Bergamaschi A, De Angelis L, Scardigli R, Galli, D., Battini, R., Bianco, P., Ferrari, Se., Cossu, G. and Ferrari, St. TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Science. 2004;117:4377-4388.
17. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, Galli R, Balconi G, Follenzi A, Frati G, et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implication for myocardium regeneration. Proc Natl Acad Sci U S A. 2001;98:10733-10738.
18. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046-1052.
19. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, Ogawa S, Okano H, Hotta T, Ando K, Fukuda K. Non-hematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004;104:3581-3587.
20. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino MA, Barresi R, Bresolin N, De Angelis MG, Campbell KP et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intraarterial delivery of mesoangioblasts. Science. 2003;301:487-492.
21. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fikel JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968-973.
22. Nakamura T, Shinya M, Matsumoto K, Sawa Y, Matsuda H. and Toshikazu Nakamura. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest. 2000;106:1511-1519.
23. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R. Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 1997;100:1991-1999.
24. Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res. 2003;57:8-19.
25. Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID, Grimmond SM, Townson S, Wells C, Little M, Cummings MC, Hayward NK, Kay GF. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 2000;86:E29-E35.